stockrowCollegium Pharmaceutical, Inc. (COLL) vs Evotec AG (EVO)
- Collegium Pharmaceutical, Inc. COLL 25.07 +5.91%
- Evotec AG EVO 1.76 +12.10%
Collegium Pharmaceutical, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $819.1M against $630.4M — 1.3× the size. Evotec AG has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 20.5×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 7.68% against 2.15%. Collegium Pharmaceutical, Inc. has the higher net margin (4.68% vs −26.2%) and the higher return on invested capital (5.63% vs 0.00%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 12 and Evotec AG on 7.
Valuation
Profitability
| Metric | COLL | EVO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 11.42% | 53.51% |
| Operating margin | 15.22% | (21.35%) | 0.00% |
| Net margin | 4.68% | (26.20%) | (2.45%) |
| Free cash flow margin | 41.25% | 0.00% | 0.00% |
| Return on equity | 13.36% | 0.00% | (0.80%) |
| Return on assets | 2.06% | 0.00% | (1.67%) |
| Return on invested capital | 5.63% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack